Goldman Sees 2016 'Flight To Quality' In These Biotech Stocks By: Benzinga via Benzinga November 18, 2015 at 11:05 AM EST Smid-cap biotech shares have pulled back significantly since July 2015. Goldman Sachs’ Salveen Richter initiated ... Read More >> Related Stocks: Biomarin Pharmaceuticals Bluebird Bio Incyte Corp Seagen Inc